Chemoinformaics analysis of 1-DODECYLPYRIDIN-1-IUM;CHLORIDE
| Molecular Weight | 283.887 | nRot | 11 |
| Heavy Atom Molecular Weight | 253.647 | nRig | 22 |
| Exact Molecular Weight | 283.207 | nRing | 1 |
| Solubility: LogS | -6.853 | nHRing | 1 |
| Solubility: LogP | 7.146 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 51.6738 |
| nHD | 0 | BPOL | 31.8062 |
| QED | 0.46 |
| Synth | 4.746 |
| Natural Product Likeliness | 3.017 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.154 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.656 |
| MDCK | 0.00000822 |
| BBB | 0.656 |
| PPB | 0.986609 |
| VDSS | 2.477 |
| FU | 0.0157507 |
| CYP1A2-inh | 0.065 |
| CYP1A2-sub | 0.657 |
| CYP2c19-inh | 0.077 |
| CYP2c19-sub | 0.947 |
| CYP2c9-inh | 0.154 |
| CYP2c9-sub | 0.196 |
| CYP2d6-inh | 0.073 |
| CYP2d6-sub | 0.888 |
| CYP3a4-inh | 0.504 |
| CYP3a4-sub | 0.697 |
| CL | 15.14 |
| T12 | 0.015 |
| hERG | 0.011 |
| Ames | 0.022 |
| ROA | 0.046 |
| SkinSen | 0.018 |
| Carcinogencity | 0.097 |
| EI | 0.009 |
| Respiratory | 0.431 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.807477 |